DiaCarta is a precision molecular diagnostics company that develops innovative oncology and infectious disease tests, providing effective precision diagnostics using liquid biopsy. The company offers a range of products and testing services, including early detection ColoScape™ Colorectal Cancer blood test, RadTox™ cfDNA test, FDA EUA approved QuantiVirus™ SARS-CoV-2 Tests, QCl...Show More